Related references
Note: Only part of the references are listed.Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss
Anna Thorso Larsen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
RAMP1 and RAMP3 Differentially Control Amylin's Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice
Bernd Coester et al.
NEUROSCIENCE (2020)
Amylin/Calcitonin Receptor-Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice
Bernd Coester et al.
DIABETES (2020)
Amylin brain circuitry
Lavinia Boccia et al.
PEPTIDES (2020)
Unsilencing of native LepRs in hypothalamic SF1 neurons does not rescue obese phenotype in LepR-deficient mice
Seraina S. Senn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2019)
Multiplexed analysis of the secretin-like GPCR-RAMP interactome
Emily Lorenzen et al.
SCIENCE ADVANCES (2019)
Receptor Activity Modifying Proteins Have Limited Effects on the Class B G Protein-Coupled Receptor Calcitonin Receptor-Like Receptor Stalk
Michael L. Garelja et al.
BIOCHEMISTRY (2018)
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity The SM-BOSS Randomized Clinical Trial
Ralph Peterli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
Christina Neuner Boyle et al.
MOLECULAR METABOLISM (2018)
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Gitanjali Srivastava et al.
CURRENT OBESITY REPORTS (2018)
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Debbie L. Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog
Sofie Gydesen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference
Sofie Gydesen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight
Sofie Gydesen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development
Rebekah L. Bower et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons
Claudia G. Liberini et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS
Sang-Min Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration
Sara T. Hjuler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2015)
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats
Kim V. Andreassen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping
Fiona E. Braegger et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats
M. Feigh et al.
HORMONE AND METABOLIC RESEARCH (2012)
A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats
M. Feigh et al.
DIABETES OBESITY & METABOLISM (2011)
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
C. M. Mack et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors
Maria Morfis et al.
ENDOCRINOLOGY (2008)
The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity
Yuka Ichikawa-Shindo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Adrenomedullin signaling is necessary for murine lymphatic vascular development
Kimberly L. Fritz-Six et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Jonathan D. Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age
Ryan Dackor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats
RD Reidelberger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: A physiological approach toward improved metabolic control
C Weyer et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema nucleus of the solitary tract (AP/NTS) lesioned rats
TA Lutz et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats
RD Reidelberger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function
K Husmann et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
